Peter G Maslak (Peter Maslak)

Years Active: 2019-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Todd L Rosenblat, Michael R McDevitt, Jorge A Carrasquillo, Neeta Pandit-Taskar, Mark G Frattini, Peter G Maslak, Jae H Park, Dan Douer, Dragan Cicic, Steven M Larson, David A Scheinberg, Joseph G Jurcic
Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (10) (2022)
Christina Y Lee, Monika K Shah, David Hoyos, Alexander Solovyov, Melanie Douglas, Ying Taur, Peter G Maslak, N Esther Babady, Benjamin Greenbaum, Mini Kamboj, Santosha A Vardhana
Prolonged SARS-CoV-2 infection in patients with lymphoid malignancies. Cancer discovery (2021)
Peter G Maslak, Tao Dao, Yvette Bernal, Suzanne M Chanel, Rong Zhang, Mark Frattini, Todd Rosenblat, Joseph G Jurcic, Renier J Brentjens, Maria E Arcila, Raajit Rampal, Jae H Park, Dan Douer, Laura Katz, Nicholas Sarlis, Martin S Tallman, David A Scheinberg
Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia. Blood advances 2 (3) (2019)

Peter G Maslak.css-eqlu8i{font-size:small;padding-left:4px;} (Peter Maslak)